NASDAQ:ANTH

Anthera Pharmaceuticals Stock Signals

etoro logo Buy ANTH
*Your capital is at risk
$0.0010
+0 (+0%)
At Close: Jul 13, 2026

Latest Data & Signals Issued

Below are some of the latest signals issued for Anthera Pharmaceuticals Inc

General

Signal Type Signal Value Data
Score 0.000 119 days ( -99,900.00 %
Last Price $0.0010 0 %
Performance History
7 Days
$0.0010 $0.0010
0%
30 Days
$0.0010 $0.0010
0%
12 Mos
$0.0001 $0.0010
900.00%

5/18

Active Buy Signals

Specific Signals

Short Term
Net score: 29.73
Signal Type Signal Value Importance Data
High / Low N/A Very Low $0.0010 - $0.0010
Trend - 3 mos 6,543.58 % High Width: 88.42 %
Pred. range - 3 mos $0.0433 - $0.0816 Low 4,228.59 % - 8,055.89 %
Volume Direction Sell High Volume: 361 · Direction: 0
Pivot Short Sell Very Low Jul 10, 2026 - 2 days
RSI Short Pivot Signal Sell Very Low Nov 30, -0001 - N/A days
Short MA 3 mos Sell Low Nov 30, -0001 - N/A days
Long MA 3 mos Sell Medium Nov 30, -0001 - N/A days
Short/Long MA 3 mos Sell Medium Nov 30, -0001 - N/A days

Unlock Short Term Signals

Get access to powerful short-term trading signals and real-time market insights

Subscribe Now
Long Term
Net score: 48.43
Signal Type Signal Value Importance Data
Trend - 12 mos 47.47 % Very High Width: 544.06 %
Pred. range - 12 mos $0.0003 - $0.0019 High -69.79 % - 94.56 %
Short MA 12 mos Sell Very High Jan 13, 2026 - 124 days
Long MA 12 mos Buy Very High Mar 17, 2026 - 81 days
Short/Long MA 12 mos Buy Very High Apr 02, 2026 - 69 days
Pivot Long Sell Low Jul 10, 2026 - 2 days
RSI Long Pivot Signal Sell Low Nov 30, -0001 - N/A days
Bollinger Sell Medium Nov 30, -0001 - N/A days
MACD Sell High No Dates Stored For This Signal
Click to get the best stock tips daily for free!
ABOUT ANTHERA PHARMACEUTICALS INC
Anthera Pharmaceuticals
Anthera Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of medicines for patients with unmet medical needs. It develops Sollpura, a non-porcine investigational pancreatic enzyme replacement therapy that is in Phase III clinical trial for the treatment of patients with exocrine pancreatic insufficiency; and Blisibimod, which is in Phase II clinical trial for the treatment of B-cell mediated auto...
GOLDEN STAR
Ticker Change Signal Date
SRPT
$17.02
11.34% Jun 29
NMRK
$15.02
1.20% Jun 24
NESR
$25.07
14.16% Jun 23
CAG
$13.43
2.98% Jun 23
GIB
$66.69
0.555% Jun 12

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE